BlackRock Inc. - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 121 filers reported holding CTI BIOPHARMA CORP in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$29,831,030
-29.7%
7,102,626
+0.6%
0.00%0.0%
Q4 2022$42,432,518
+10.5%
7,060,319
+7.0%
0.00%0.0%
Q3 2022$38,405,000
+9.2%
6,598,773
+12.0%
0.00%0.0%
Q2 2022$35,170,000
+320.3%
5,890,969
+228.8%
0.00%
Q1 2022$8,367,000
+87.5%
1,791,693
-0.4%
0.00%
Q4 2021$4,462,000
+68.9%
1,798,830
+100.9%
0.00%
Q3 2021$2,642,000
+17.7%
895,391
-0.2%
0.00%
Q2 2021$2,244,000
-17.1%
897,051
-3.6%
0.00%
Q1 2021$2,708,000
-7.6%
930,610
+2.3%
0.00%
Q4 2020$2,931,000
+46.9%
910,037
-2.0%
0.00%
Q3 2020$1,995,000
+84.7%
928,279
-0.3%
0.00%
Q2 2020$1,080,000
+55.8%
931,466
+23.6%
0.00%
Q1 2020$693,000
-28.3%
753,316
+23.2%
0.00%
Q4 2019$966,000
+237.8%
611,506
+79.4%
0.00%
Q3 2019$286,000
-2.1%
340,951
+0.2%
0.00%
Q2 2019$292,000
-89.2%
340,125
-87.8%
0.00%
Q1 2019$2,711,000
+27.7%
2,794,715
-3.4%
0.00%
Q4 2018$2,123,000
-65.9%
2,893,856
+0.3%
0.00%
Q3 2018$6,230,000
-55.4%
2,884,361
+2.9%
0.00%
-100.0%
Q2 2018$13,958,000
+725.4%
2,803,182
+546.2%
0.00%
Q1 2018$1,691,000
+52.1%
433,784
+4.5%
0.00%
Q4 2017$1,112,000
-14.5%
415,118
+1.9%
0.00%
Q3 2017$1,300,000
+1.5%
407,532
+5.4%
0.00%
Q2 2017$1,281,000
-14.0%
386,769
+9.0%
0.00%
Q1 2017$1,490,000354,7000.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 6,535,674$27,449,8319.21%
Bleichroeder LP 3,893,730$16,353,6663.49%
AIGH Capital Management LLC 2,100,000$8,820,0003.25%
Ally Bridge Group (NY) LLC 550,000$2,310,0003.03%
Ghost Tree Capital, LLC 2,000,000$8,400,0002.48%
Bain Capital Life Sciences Investors, LLC 4,702,996$19,7532.47%
Altium Capital Management LP 850,000$3,570,0001.98%
Parkman Healthcare Partners LLC 1,753,630$7,365,2461.60%
BVF INC/IL 8,813,021$37,014,6881.35%
Sio Capital Management, LLC 526,239$2,210,2041.09%
View complete list of CTI BIOPHARMA CORP shareholders